mTOR: from growth signal integration to cancer, diabetes and ageing

By Roberto Zoncu, David M. Sabatini, A. Efeyan. Nature reviews. Molecular cell biology, 2010

4,005 citations recorded by the source corpus.

In all eukaryotes, the target of rapamycin (TOR) signalling pathway couples energy and nutrient abundance to the execution of cell growth and division, owing to the ability of TOR protein kinase to simultaneously sense energy, nutrients and stress and, in metazoans, growth factors. Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt. In the past few years, a significant advance in our understanding of the regulation and functions of mTOR has revealed the crucial involvement of this signalling pathway in the onset and progression of diabetes, cancer and ageing.

Subfields: Aging, Molecular Biology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/0e0703cf80d88907c4c1dfb4bae4dd7c0fd5dffc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Aging

  1. David M. Sabatini
  2. Nir Barzilai
  3. Roberto Zoncu
  4. T. Blackwell
  5. S. Imai
  6. D. Hardie
  7. L. Guarente

In Molecular Biology

  1. David M. Sabatini
  2. Michael N. Hall
  3. C. V. Dang
  4. J. Blenis
  5. M. Laplante
  6. Nahum Sonenberg
  7. R. Loewith
  8. Roberto Zoncu

In Pharmacology

  1. David M. Sabatini
  2. Michael N. Hall
  3. R. Loewith
  4. Ruth Nussinov
  5. Peter Csermely
  6. Huba J. M. Kiss
  7. T. Balla
  8. Tamás Korcsmáros

Citations in the corpus